Contact

All Stories

  1. Long-Term Effect of Physical Exercise on the Risk for Hospitalization and Death in Dialysis Patients

    Article • Clinical Journal of the American Society of Nephrology, July 2022, American Society of Nephrology

    Prof. Carmine Zoccali

  2. Humoral Response to Third Dose of SARS-CoV-2 Vaccines in the CKD Spectrum

    Article • Clinical Journal of the American Society of Nephrology, May 2022, American Society of Nephrology

    Prof. Carmine Zoccali

  3. Detecting and Treating Lung Congestion with Kidney Failure

    Article • Clinical Journal of the American Society of Nephrology, February 2022, American Society of Nephrology

    Prof. Carmine Zoccali

  4. Noninvasive Diagnosis of PLA2R-Associated Membranous Nephropathy

    Article • Clinical Journal of the American Society of Nephrology, November 2021, American Society of Nephrology

    Prof. Carmine Zoccali

  5. Tales of two study designs in patients with chronic kidney failure: The case of the protein–energy wasting – inflammation syndromic complex

    Article • Journal of Internal Medicine, June 2021, Wiley

    Prof. Carmine Zoccali

  6. Renin-Angiotensin System Blockers and the Risk of COVID-19–Related Mortality in Patients with Kidney Failure

    Article • Clinical Journal of the American Society of Nephrology, June 2021, American Society of Nephrology

    Prof. Carmine Zoccali, Maria José Soler, Dr Augusto Cesar Soares dos Santos Junior, Haridian Sosa

  7. Novel Therapeutic Options for Cardiovascular Disease with CKD

    Article • Clinical Journal of the American Society of Nephrology, April 2021, American Society of Nephrology

    Prof. Carmine Zoccali

  8. Undernutrition in childhood and adolescence and atherosclerosis in adult life

    Article • Nutrition Metabolism and Cardiovascular Diseases, March 2021, Elsevier

    Prof. Carmine Zoccali

  9. Sleep Apnea as a Cardiorenal Risk Factor in CKD and Renal Transplant Patients

    Article • Blood Purification, February 2021, Karger Publishers

    Prof. Carmine Zoccali

  10. Epidemiology of hyperkalemia in CKD patients under nephrological care: a longitudinal study

    Article • Internal and Emergency Medicine, February 2021, Springer Science + Business Media

    Prof. Carmine Zoccali

  11. The Innate Immune System and Cardiovascular Disease in ESKD: Monocytes and Natural Killer Cells

    Article • Current Vascular Pharmacology, December 2020, Bentham Science Publishers

    Prof. Carmine Zoccali, Professor Katerina K Naka

  12. Endothelial Dysfunction in Chronic Kidney Disease, from Biology to Clinical Outcomes: A 2020 Update

    Article • Journal of Clinical Medicine, July 2020, MDPI AG

    Prof. Carmine Zoccali

  13. Sleep‐Disordered Breathing and 24‐Hour Ambulatory Blood Pressure Monitoring in Renal Transplant Patients: Longitudinal Study

    Article • Journal of the American Heart Association, July 2020, Wolters Kluwer Health

    Prof. Carmine Zoccali

  14. Should We Continue Assessing Glomerular Filtration Rate with the Cockroft–Gault Formula in NOAC-Treated Patients? The Magnitude of the Problem

    Article • Journal of Clinical Medicine, June 2020, MDPI AG

    Prof. Carmine Zoccali

  15. Long-Term Changes in Sleep Disordered Breathing in Renal Transplant Patients: Relevance of the BMI

    Article • Journal of Clinical Medicine, June 2020, MDPI AG

    Prof. Carmine Zoccali

  16. FGF23 and the PTH response to paricalcitol in chronic kidney disease

    Article • European Journal of Clinical Investigation, January 2020, Wiley

    Prof. Carmine Zoccali

  17. Lung ultrasound to detect and monitor pulmonary congestion in patients with acute kidney injury in nephrology wards: a pilot study

    Article • Journal of Nephrology, November 2019, Springer Science + Business Media

    Prof. Carmine Zoccali

  18. A single number for advocacy and communication—worldwide more than 850 million individuals have kidney diseases

    Article • Kidney International, November 2019, Elsevier

    Prof. Carmine Zoccali

  19. Urine chloride self-measurement to monitor sodium chloride intake in patients with chronic kidney disease

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), July 2019, De Gruyter

    Prof. Carmine Zoccali

  20. Blood Pressure Variability, Mortality, and Cardiovascular Outcomes in CKD Patients

    Article • Clinical Journal of the American Society of Nephrology, January 2019, American Society of Nephrology

    Prof. Carmine Zoccali

  21. Mutations in the GLA Gene and LysoGb3: Is It Really Anderson-Fabry Disease?

    Article • International Journal of Molecular Sciences, November 2018, MDPI AG

    Prof. Carmine Zoccali

  22. Mapping Progress in Reducing Cardiovascular Risk with Kidney Disease

    Article • Clinical Journal of the American Society of Nephrology, August 2018, American Society of Nephrology

    Prof. Carmine Zoccali

  23. The Ebb and Flow of Echocardiographic Cardiac Function Parameters in Relationship to Hemodialysis Treatment in Patients with ESRD

    Article • Journal of the American Society of Nephrology, March 2018, American Society of Nephrology

    Prof. Carmine Zoccali

  24. Anterior robotic approach in en-bloc sacrectomy: a preliminary experience

    Article • Journal of Robotic Surgery, March 2018, Springer Science + Business Media

    Prof. Carmine Zoccali

  25. Vitamin D and methylarginines in chronic kidney disease (CKD)

    Article • PLoS ONE, October 2017, PLOS

    Prof. Carmine Zoccali

  26. Chronic Fluid Overload and Mortality in ESRD

    Article • Journal of the American Society of Nephrology, May 2017, American Society of Nephrology

    Prof. Carmine Zoccali

  27. Moderator’s view: Predictive models: a prelude to precision nephrology

    Article • Nephrology Dialysis Transplantation, May 2017, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  28. Effect of Vitamin D Receptor Activation on the AGE/RAGE System and Myeloperoxidase in Chronic Kidney Disease Patients

    Article • Oxidative Medicine and Cellular Longevity, January 2017, Hindawi Publishing Corporation

    Prof. Carmine Zoccali

  29. Lung Ultrasound in Dialysis patients

    Article • Clinical Journal of the American Society of Nephrology, September 2016, American Society of Nephrology

    Professor Robert Ekart, Dr Luna Gargani, Dr Aristeidis Stavroulopoulos, Prof Itzchak Slotki, enrico fiaccadori, Prof Alberto M Martínez-Castelao, Dr Claudia Torino, Dr Rosa Sicari, Prof. Carmine Zoccali, Dr Gerard M LONDON

  30. Faculty Opinions recommendation of Predictive Value of the sFlt-1:PlGF Ratio in Women with Suspected Preeclampsia.

    Article • January 2016, F1000Research

    Prof. Carmine Zoccali

  31. Oxidative Stress as Estimated by Gamma-Glutamyl Transferase Levels Amplifies the Alkaline Phosphatase-Dependent Risk for Mortality in ESKD Patients on Dialysis

    Article • Oxidative Medicine and Cellular Longevity, January 2016, Hindawi Publishing Corporation

    Prof. Carmine Zoccali

  32. Cocoa Flavanols: A Magic Potion for Protecting the Endothelium in Kidney Failure?

    Article • Clinical Journal of the American Society of Nephrology, December 2015, American Society of Nephrology

    Prof. Carmine Zoccali, Dr Gerard M LONDON

  33. Asymmetric and Symmetric Dimethylarginine and Sympathetic Nerve Traffic after Renal Denervation in Patients with Resistant Hypertension

    Article • Clinical Journal of the American Society of Nephrology, July 2015, American Society of Nephrology

    Professor guido M Grassi, Prof. Carmine Zoccali, giuseppe mancia

  34. Seven essential tools of a cardiologist's survival kit

    Article • International Journal of Cardiology, July 2015, Elsevier

    Prof. Carmine Zoccali

  35. Should patients with CKD stage 5D and biochemical evidence of secondary hyperparathyroidism be prescribed calcimimetic therapy? An ERA-EDTA position statement

    Article • Nephrology Dialysis Transplantation, March 2015, Oxford University Press (OUP)

    Sandro Mazzaferro, Prof. Carmine Zoccali

  36. A Longitudinal Study of Inflammation, CKD-Mineral Bone Disorder, and Carotid Atherosclerosis after Renal Transplantation

    Article • Clinical Journal of the American Society of Nephrology, December 2014, American Society of Nephrology

    Professor Mahmut I Yilmaz, Dr. Selim KILIC, Prof. Carmine Zoccali

  37. Association of IL-6 and a Functional Polymorphism in the IL-6 Gene with Cardiovascular Events in Patients with CKD

    Article • Clinical Journal of the American Society of Nephrology, December 2014, American Society of Nephrology

    Prof. Carmine Zoccali

  38. Erratum

    Article • Nephrology Dialysis Transplantation, October 2014, Oxford University Press (OUP)

    prof alberto ortiz , Prof. Carmine Zoccali

  39. Epidemiology, contributors to, and clinical trials of mortality risk in chronic kidney failure

    Article • The Lancet, May 2014, Elsevier

    prof alberto ortiz , Prof. Carmine Zoccali

  40. Association of a Polymorphism in a Gene Encoding a Urate Transporter with CKD Progression

    Article • Clinical Journal of the American Society of Nephrology, April 2014, American Society of Nephrology

    Prof. Carmine Zoccali

  41. Faculty Opinions recommendation of Serum calcification propensity predicts all-cause mortality in predialysis CKD.

    Article • February 2014, F1000Research

    Prof. Carmine Zoccali

  42. Phosphate levels in patients treated with low-flux haemodialysis, pre-dilution haemofiltration and haemodiafiltration: post hoc analysis of a multicentre, randomized and controlled trial

    Article • Nephrology Dialysis Transplantation, February 2014, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  43. Faculty Opinions recommendation of Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease.

    Article • December 2013, F1000Research

    Prof. Carmine Zoccali

  44. Use of phosphate-binding agents is associated with a lower risk of mortality

    Article • Kidney International, November 2013, Elsevier

    Prof.dr.sc. Drasko Pavlovic, Prof. Carmine Zoccali

  45. Lung congestion as a hidden threat in end-stage kidney disease: a call to action

    Article • Nephrology Dialysis Transplantation, October 2013, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  46. Estimated Glomerular Filtration Rate, All-Cause Mortality and Cardiovascular Diseases Incidence in a Low Risk Population: The MATISS Study

    Article • PLoS ONE, October 2013, PLOS

    Prof. Carmine Zoccali

  47. Obesity in CKD—What Should Nephrologists Know?

    Article • Journal of the American Society of Nephrology, October 2013, American Society of Nephrology

    Prof. Carmine Zoccali

  48. Effects of weight loss on renal function in obese CKD patients: a systematic review

    Article • Nephrology Dialysis Transplantation, October 2013, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  49. Assessment of arterial stiffness for clinical and epidemiological studies: methodological considerations for validation and entry into the European Renal and Cardiovascular Medicine registry

    Article • Nephrology Dialysis Transplantation, September 2013, Oxford University Press (OUP)

    prof alberto ortiz , Prof. Carmine Zoccali

  50. Uric Acid, Hypertension, and Cardiovascular and Renal Complications

    Article • Current Hypertension Reports, September 2013, Springer Science + Business Media

    Prof. Carmine Zoccali

  51. Longitudinal association of body mass index and waist circumference with left ventricular mass in hypertensive predialysis chronic kidney disease patients

    Article • Nephrology Dialysis Transplantation, September 2013, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  52. Influence of Body Mass Index on the Association of Weight Changes with Mortality in Hemodialysis Patients

    Article • Clinical Journal of the American Society of Nephrology, September 2013, American Society of Nephrology

    Dr Drasko Pavlovic, Prof. Carmine Zoccali, Prof. Aníbal A Ferreira, Dr Gerard M LONDON, dr Dierik L Verbeelen, Jürgen Floege, Nagy Judit, Prof.dr.sc. Drasko Pavlovic

  53. Vascular calcification in chronic kidney disease: are biomarkers useful for probing the pathobiology and the health risks of this process in the clinical scenario?

    Article • Nephrology Dialysis Transplantation, September 2013, Oxford University Press (OUP)

    prof alberto ortiz , Prof. Carmine Zoccali

  54. Homoarginine and Mortality in Pre-Dialysis Chronic Kidney Disease (CKD) Patients

    Article • PLoS ONE, September 2013, PLOS

    Prof. Carmine Zoccali

  55. Low triiodothyronine: a pathway to coronary calcification in patients maintained on peritoneal dialysis

    Article • Journal of Internal Medicine, September 2013, Wiley

    Prof. Carmine Zoccali

  56. When do we need competing risks methods for survival analysis in nephrology?

    Article • Nephrology Dialysis Transplantation, August 2013, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  57. Resistin and all-cause and cardiovascular mortality: effect modification by adiponectin in end-stage kidney disease patients

    Article • Nephrology Dialysis Transplantation, August 2013, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  58. Letter to the editor about the reviewer comment to our article entitled ‘Procalcitonin and the inflammatory response to salt in essential hypertension

    Article • Journal of Hypertension, August 2013, Wolters Kluwer Health

    Prof. Carmine Zoccali

  59. Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease

    Article • Kidney International, August 2013, Elsevier

    Prof. Carmine Zoccali

  60. Procalcitonin and the inflammatory response to salt in essential hypertension

    Article • Journal of Hypertension, July 2013, Wolters Kluwer Health

    Prof. Carmine Zoccali

  61. Catheter-based renal denervation as a novel treatment for loin pain haematuria syndrome

    Article • Nephrology Dialysis Transplantation, June 2013, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  62. Obesity and nephrology: results of a knowledge and practice pattern survey

    Article • Nephrology Dialysis Transplantation, June 2013, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  63. The new NDT series Ideas, Conjectures and Refutations (ICR): elegance in nephrology research

    Article • Nephrology Dialysis Transplantation, June 2013, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  64. Multiple imputation: dealing with missing data

    Article • Nephrology Dialysis Transplantation, May 2013, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  65. Risk prediction models

    Article • Nephrology Dialysis Transplantation, May 2013, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  66. Spleen IL-10, a key player in obesity-driven renal risk

    Article • Nephrology Dialysis Transplantation, May 2013, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  67. Erratum to: The quality of reporting in clinical research: the CONSORT and STROBE initiatives

    Article • Aging Clinical and Experimental Research, April 2013, Springer Science + Business Media

    Prof. Carmine Zoccali

  68. Asymmetric dimethylarginine predicts survival in the elderly

    Article • AGE, April 2013, Springer Science + Business Media

    Prof. Carmine Zoccali

  69. pulmonary congestion dialysis

    Article • Clinical Journal of the American Society of Nephrology, April 2013, American Society of Nephrology

    Dr Claudia Torino, Prof. Carmine Zoccali, medical doctor Vincenzo Panuccio

  70. Pulmonary Hypertension in CKD

    Article • American Journal of Kidney Diseases, April 2013, Elsevier

    prof alberto ortiz , Prof. Carmine Zoccali

  71. Albuminuria in the Normal Range

    Article • Journal of the American College of Cardiology, April 2013, Elsevier

    Prof. Carmine Zoccali

  72. The quality of reporting in clinical research: the CONSORT and STROBE initiatives

    Article • Aging Clinical and Experimental Research, April 2013, Springer Science + Business Media

    Prof. Carmine Zoccali

  73. Current World Literature

    Article • Current Opinion in Nephrology & Hypertension, March 2013, Wolters Kluwer Health

    Prof. Carmine Zoccali

  74. Pulmonary Congestion Predicts Cardiac Events and Mortality in ESRD

    Article • Journal of the American Society of Nephrology, February 2013, American Society of Nephrology

    Prof. Carmine Zoccali

  75. Healthcare workers and prevention of hepatitis C virus transmission: exploring knowledge, attitudes and evidence-based practices in hemodialysis units in Italy

    Article • BMC Infectious Diseases, February 2013, Springer Science + Business Media

    Prof. Carmine Zoccali

  76. Age, stage and biomarkers for the definition of CKD: a construction in progress

    Article • Clinical Chemistry and Laboratory Medicine (CCLM), January 2013, De Gruyter

    Prof. Carmine Zoccali

  77. Corrigendum to “Glitazones in chronic kidney disease: Potential and concerns” [Nutr Metab Cardiovasc Dis 22 (2012) 167–175]

    Article • Nutrition Metabolism and Cardiovascular Diseases, January 2013, Elsevier

    Prof. Carmine Zoccali

  78. FGF23: A Mature Renal and Cardiovascular Risk Factor?

    Article • Blood Purification, January 2013, Karger Publishers

    Prof. Carmine Zoccali

  79. Joint effect of insulin signaling genes on cardiovascular events and on whole body and endothelial insulin resistance

    Article • Atherosclerosis, January 2013, Elsevier

    Prof. Carmine Zoccali

  80. Longitudinal Analysis of Vascular Function and Biomarkers of Metabolic Bone Disorders before and after Renal Transplantation

    Article • American Journal of Nephrology, January 2013, Karger Publishers

    Prof. Carmine Zoccali

  81. Vitamin D reduces left atrial volume in patients with left ventricular hypertrophy and chronic kidney disease

    Article • American Heart Journal, December 2012, Elsevier

    Prof. Carmine Zoccali

  82. Cultural adaptation and validation of the “Kidney Disease and Quality of Life - Short Form (KDQOL-SF™) version 1.3” questionnaire in Egypt

    Article • BMC Nephrology, December 2012, Springer Science + Business Media

    Prof. Carmine Zoccali

  83. Hypertension and cardiovascular risk in chronic kidney disease

    Article • Nephrology Dialysis Transplantation, December 2012, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  84. Notice

    Article • Kidney International Supplements, December 2012, Elsevier

    Prof. Carmine Zoccali

  85. Pulmonary embolism in chronic kidney disease: a lethal, overlooked and research orphan disease

    Article • Journal of Thrombosis and Haemostasis, December 2012, Wiley

    Prof. Carmine Zoccali

  86. The fat-mass and obesity-associated gene (FTO) predicts mortality in chronic kidney disease of various severity

    Article • Nephrology Dialysis Transplantation, December 2012, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  87. Phosphate attenuates the anti-proteinuric effect of very low-protein diet in CKD patients

    Article • Nephrology Dialysis Transplantation, November 2012, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  88. Updating the lipids hypothesis of inflammation and vascular disease in patients with chronic kidney disease: a stearoyl-CoA desaturase affair?

    Article • Journal of Internal Medicine, November 2012, Wiley

    Prof. Carmine Zoccali

  89. Assessment of obesity in chronic kidney disease

    Article • Current Opinion in Nephrology & Hypertension, November 2012, Wolters Kluwer Health

    Prof. Carmine Zoccali

  90. Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients

    Article • Nutrition Metabolism and Cardiovascular Diseases, November 2012, Elsevier

    Prof. Carmine Zoccali

  91. The use of echocardiography in observational clinical trials: the EURECA-m registry

    Article • Nephrology Dialysis Transplantation, October 2012, Oxford University Press (OUP)

    prof alberto ortiz , Prof. Carmine Zoccali

  92. Pro-inflammatory cytokines and bone fractures in CKD patients. An exploratory single centre study

    Article • BMC Nephrology, October 2012, Springer Science + Business Media

    Prof. Carmine Zoccali

  93. Pulmonary hypertension in dialysis patients: a prevalent, risky but still uncharacterized disorder

    Article • Nephrology Dialysis Transplantation, October 2012, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  94. Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD)

    Article • Nutrition Metabolism and Cardiovascular Diseases, September 2012, Elsevier

    Prof. Carmine Zoccali

  95. Hepatocyte Growth Factor and Cardiomyopathy in Dialysis Patients

    Article • Hypertension, September 2012, Wolters Kluwer Health

    Prof. Carmine Zoccali

  96. Pulmonary Congestion and Physical Functioning in Peritoneal Dialysis Patients

    Article • Peritoneal Dialysis International, September 2012, SAGE Publications

    Prof. Carmine Zoccali

  97. The effect of increasing age on the prognosis of non-dialysis patients with chronic kidney disease receiving stable nephrology care

    Article • Kidney International, August 2012, Elsevier

    Prof. Maurizio Gallieni, Prof. Carmine Zoccali

  98. Antidepressants for depression in stage 3–5 chronic kidney disease: a systematic review of pharmacokinetics, efficacy and safety with recommendations by European Renal Best Practice (ERBP)*

    Article • Nephrology Dialysis Transplantation, August 2012, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  99. Instrumental variable analysis

    Article • Nephrology Dialysis Transplantation, July 2012, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  100. Renal artery stenting is ineffective to reduce LV hypertrophy

    Article • American Journal of Kidney Diseases, July 2012, Elsevier

    Dr Luca Zanoli, Prof. Carmine Zoccali

  101. European guidelines on when to start dialysis: check the facts first before commenting

    Article • Kidney International, June 2012, Elsevier

    Prof. Carmine Zoccali

  102. Predictors of haemoglobin levels and resistance to erythropoiesis-stimulating agents in patients treated with low-flux haemodialysis, haemofiltration and haemodiafiltration: results of a multicentre randomized and controlled trial

    Article • Nephrology Dialysis Transplantation, May 2012, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  103. Chest ultrasound and hidden lung congestion in peritoneal dialysis patients

    Article • Nephrology Dialysis Transplantation, May 2012, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  104. The burden of physical inactivity in chronic kidney disease: is there an exit strategy?

    Article • Nephrology Dialysis Transplantation, May 2012, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  105. Monocyte subpopulations and cardiovascular risk in chronic kidney disease

    Article • Nature Reviews Nephrology, March 2012, Nature

    prof alberto ortiz , Prof. Carmine Zoccali

  106. Glitazones in chronic kidney disease: Potential and concerns

    Article • Nutrition Metabolism and Cardiovascular Diseases, March 2012, Elsevier

    Prof. Carmine Zoccali

  107. Vitamin D Therapy and Cardiac Structure and Function in Patients With Chronic Kidney Disease

    Article • JAMA, February 2012, American Medical Association (AMA)

    Prof. Carmine Zoccali

  108. Comparison of Calcium Acetate and Sevelamer on Vascular Function and Fibroblast Growth Factor 23 in CKD Patients: A Randomized Clinical Trial

    Article • American Journal of Kidney Diseases, February 2012, Elsevier

    Prof. Carmine Zoccali

  109. eNOS and Caveolin-1 Gene Polymorphisms Interaction and Intima Media Thickness: A Proof of Concept Study in ESRD Patients

    Article • American Journal of Hypertension, January 2012, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  110. Heart rate, age and the risk of progression to kidney failure in patients with CKD

    Article • Journal of Nephrology, January 2012, SAGE Publications

    Prof. Carmine Zoccali

  111. Measuring Agreement, More Complicated Than It Seems

    Article • Nephron Clinical Practice, January 2012, Karger Publishers

    Prof. Carmine Zoccali

  112. Measuring asymmetric dimethylarginine (ADMA) in CKD: a comparison between enzyme-linked immunosorbent assay and liquid chromatography-electrospray tandem mass spectrometry

    Article • Journal of Nephrology, January 2012, SAGE Publications

    Prof. Carmine Zoccali

  113. Report from the Editorial Offices

    Article • Nephrology Dialysis Transplantation, January 2012, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  114. The MAURO study: baseline characteristics and compliance with guidelines targets

    Article • Journal of Nephrology, January 2012, SAGE Publications

    Prof. Carmine Zoccali

  115. Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure

    Article • Nephrology Dialysis Transplantation, December 2011, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  116. Thyroid Function and Clinical Outcomes in Kidney Failure

    Article • Clinical Journal of the American Society of Nephrology, December 2011, American Society of Nephrology

    Prof. Carmine Zoccali

  117. Clinical usefulness of novel prognostic biomarkers in patients on hemodialysis

    Article • Nature Reviews Nephrology, November 2011, Nature

    prof alberto ortiz , Prof. Carmine Zoccali

  118. Sympathoinhibitory effects of statins in chronic kidney disease

    Article • Journal of Hypertension, November 2011, Wolters Kluwer Health

    Prof. Carmine Zoccali

  119. Sympathetic Nerve Traffic and Asymmetric Dimethylarginine in Chronic Kidney Disease

    Article • Clinical Journal of the American Society of Nephrology, September 2011, American Society of Nephrology

    Prof. Carmine Zoccali

  120. Aging and Left Ventricular Mass and Function in People with End-Stage Renal Disease

    Article • Journal of the American Geriatrics Society, August 2011, Wiley

    Prof. Carmine Zoccali

  121. Phosphate May Promote CKD Progression and Attenuate Renoprotective Effect of ACE Inhibition

    Article • Journal of the American Society of Nephrology, August 2011, American Society of Nephrology

    Prof. Carmine Zoccali

  122. Prognosis of CKD Patients Receiving Outpatient Nephrology Care in Italy

    Article • Clinical Journal of the American Society of Nephrology, August 2011, American Society of Nephrology

    Prof. Carmine Zoccali

  123. Obesity and the Epidemiology and Prevention of Kidney Disease: Waist Circumference Versus Body Mass Index

    Article • American Journal of Kidney Diseases, August 2011, Elsevier

    Prof. Carmine Zoccali

  124. Inflammation and Asymmetric Dimethylarginine for Predicting Death and Cardiovascular Events in ESRD Patients

    Article • Clinical Journal of the American Society of Nephrology, June 2011, American Society of Nephrology

    Prof. Carmine Zoccali

  125. Arterial aging and arterial disease: interplay between central hemodynamics, cardiac work, and organ flow—implications for CKD and cardiovascular disease

    Article • Kidney International Supplements, June 2011, Elsevier

    prof alberto ortiz , Prof. Carmine Zoccali

  126. Cardiovascular and non-cardiovascular mortality in dialysis patients: where is the link?

    Article • Kidney International Supplements, June 2011, Elsevier

    prof alberto ortiz , Prof. Carmine Zoccali

  127. Major pathways of the reno–cardiovascular link: the sympathetic and renin–angiotensin systems

    Article • Kidney International Supplements, June 2011, Elsevier

    prof alberto ortiz , Prof. Carmine Zoccali

  128. The complexity of the cardio–renal link: taxonomy, syndromes, and diseases

    Article • Kidney International Supplements, June 2011, Elsevier

    prof alberto ortiz , Prof. Carmine Zoccali

  129. The dysfunctional endothelium in CKD and in cardiovascular disease: mapping the origin(s) of cardiovascular problems in CKD and of kidney disease in cardiovascular conditions for a research agenda

    Article • Kidney International Supplements, June 2011, Elsevier

    prof alberto ortiz , Prof. Carmine Zoccali

  130. The lingering dilemma of arterial pressure in CKD: what do we know, where do we go?

    Article • Kidney International Supplements, June 2011, Elsevier

    prof alberto ortiz , Prof. Carmine Zoccali

  131. Cardiovascular and renal medicine, an expanding territory

    Article • Kidney International Supplements, June 2011, Elsevier

    Prof. Carmine Zoccali

  132. Insulin resistance and left ventricular hypertrophy in end-stage renal disease: association between the ENPP1 gene and left ventricular concentric remodelling

    Article • Nephrology Dialysis Transplantation, May 2011, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  133. When to start dialysis: updated guidance following publication of the Initiating Dialysis Early and Late (IDEAL) study

    Article • Nephrology Dialysis Transplantation, May 2011, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  134. ACE Inhibition Is Renoprotective among Obese Patients with Proteinuria

    Article • Journal of the American Society of Nephrology, April 2011, American Society of Nephrology

    Prof. Carmine Zoccali

  135. Smoking and hyperparathyroidism in patients with end-stage renal disease (ESRD)

    Article • Journal of Nephrology, April 2011, SAGE Publications

    Prof. Carmine Zoccali

  136. Abdominal obesity modifies the risk of hypertriglyceridemia for all-cause and cardiovascular mortality in hemodialysis patients

    Article • Kidney International, April 2011, Elsevier

    Prof. Carmine Zoccali

  137. The use of group sequential, information-based sample size re-estimation in the design of the PRIMO study of chronic kidney disease

    Article • Clinical Trials, April 2011, SAGE Publications

    Prof. Carmine Zoccali

  138. TheENPP1Q121 Variant Predicts Major Cardiovascular Events in High-Risk Individuals

    Article • Diabetes, January 2011, American Diabetes Association

    Prof. Carmine Zoccali

  139. Does adipose tissue have a key role in inflammation in CKD?

    Article • Journal of Internal Medicine, January 2011, Wiley

    Prof. Carmine Zoccali

  140. Dyslipidemia in Chronic Renal Disease

    Article • January 2011, Wiley

    Prof. Carmine Zoccali

  141. Role of Obesity and Metabolic Alterations in Hypertensive Renal Disease and in Chronic Kidney Disease

    Article • January 2011, Wiley

    Prof. Carmine Zoccali

  142. Adding Up the Evidence: Systematic Reviews and Meta-Analyses

    Article • Nephron Clinical Practice, January 2011, Karger Publishers

    Prof. Carmine Zoccali

  143. Adiponectin and Leptin in Chronic Kidney Disease: Causal Factors or Mere Risk Markers?

    Article • Journal of Renal Nutrition, January 2011, Elsevier

    Prof. Carmine Zoccali

  144. Genetic Association Studies: Discovery of the Genetic Basis of Renal Disease

    Article • Nephron Clinical Practice, January 2011, Karger Publishers

    Prof. Carmine Zoccali

  145. How to Deal with Continuous and Dichotomic Outcomes in Epidemiological Research: Linear and Logistic Regression Analyses

    Article • Nephron Clinical Practice, January 2011, Karger Publishers

    Prof. Carmine Zoccali

  146. Interaction on an Additive Scale

    Article • Nephron Clinical Practice, January 2011, Karger Publishers

    Prof. Carmine Zoccali

  147. Left Ventricular Mass Index as an Outcome Measure in Clinical Trials in Dialysis Patients: A Word of Caution

    Article • American Journal of Nephrology, January 2011, Karger Publishers

    Prof. Carmine Zoccali

  148. Low Triiodothyronine Alters Flow-Mediated Vasodilatation in Advanced Nondiabetic Kidney Disease

    Article • American Journal of Nephrology, January 2011, Karger Publishers

    Prof. Carmine Zoccali

  149. Matching, an Appealing Method to Avoid Confounding?

    Article • Nephron Clinical Practice, January 2011, Karger Publishers

    Prof. Carmine Zoccali

  150. Reporting of Interaction

    Article • Nephron Clinical Practice, January 2011, Karger Publishers

    Prof. Carmine Zoccali

  151. Sample Size Calculations

    Article • Nephron Clinical Practice, January 2011, Karger Publishers

    Prof. Carmine Zoccali

  152. Survival Analysis I: The Kaplan-Meier Method

    Article • Nephron Clinical Practice, January 2011, Karger Publishers

    Prof. Carmine Zoccali

  153. Survival Analysis II: Cox Regression

    Article • Nephron Clinical Practice, January 2011, Karger Publishers

    Prof. Carmine Zoccali

  154. The Dilemma of Making Recommendations Based on Weak Evidence

    Article • Seminars in Dialysis, January 2011, Wiley

    Prof. Carmine Zoccali

  155. Ultrafiltration intensification in hemodialysis patients improves hypertension but increases AV fistula complications and cardiovascular events.

    Article • Journal of Nephrology, January 2011, SAGE Publications

    Prof. Carmine Zoccali

  156. Vitamin D Receptor Activation and Left Ventricular Hypertrophy in Advanced Kidney Disease

    Article • American Journal of Nephrology, January 2011, Karger Publishers

    Prof. Carmine Zoccali

  157. Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients

    Article • Journal of Internal Medicine, December 2010, Wiley

    Prof. Carmine Zoccali

  158. Traditional and nontraditional risk factors as predictors of cerebrovascular events in patients with end stage renal disease

    Article • Journal of Hypertension, December 2010, Wolters Kluwer Health

    Prof. Carmine Zoccali

  159. What makes plaques vulnerable in CKD?: a fresh look at metalloproteinases

    Article • Kidney International, December 2010, Elsevier

    Prof. Carmine Zoccali

  160. Hyperhomocysteinemia: a renal and cardiovascular risk factor?

    Article • Nature Reviews Nephrology, November 2010, Springer Science + Business Media

    Prof. Carmine Zoccali

  161. Ranolazine can markedly increase tacrolimus blood levels

    Article • Clinical Kidney Journal, October 2010, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  162. FGF-23 and vascular dysfunction in patients with stage 3 and 4 chronic kidney disease

    Article • Kidney International, October 2010, Elsevier

    Prof. Carmine Zoccali

  163. Sample size calculations: basic principles and common pitfalls

    Article • Nephrology Dialysis Transplantation, September 2010, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  164. The issue of studying the effect of interventions in renal replacement therapy -- to what extent may we be deceived by selection and competing risk?

    Article • Nephrology Dialysis Transplantation, September 2010, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  165. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Guidelines: a European Renal Best Practice (ERBP) commentary statement

    Article • Nephrology Dialysis Transplantation, September 2010, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  166. Hemofiltration and Hemodiafiltration Reduce Intradialytic Hypotension in ESRD

    Article • Journal of the American Society of Nephrology, September 2010, American Society of Nephrology

    Prof. Carmine Zoccali

  167. Vasopressin beyond water: implications for renal diseases

    Article • Current Opinion in Nephrology & Hypertension, September 2010, Wolters Kluwer Health

    Prof. Carmine Zoccali

  168. Left Ventricular Systolic Dysfunction

    Article • Hypertension, August 2010, Wolters Kluwer Health

    Prof. Carmine Zoccali

  169. Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients

    Article • Journal of Hypertension, August 2010, Wolters Kluwer Health

    Prof. Carmine Zoccali

  170. Stratification for Confounding – Part 1: The Mantel-Haenszel Formula

    Article • Nephron Clinical Practice, July 2010, Karger Publishers

    Prof. Carmine Zoccali

  171. Stratification for Confounding – Part 2: Direct and Indirect Standardization

    Article • Nephron Clinical Practice, July 2010, Karger Publishers

    Prof. Carmine Zoccali

  172. Detection of Pulmonary Congestion by Chest Ultrasound in Dialysis Patients

    Article • JACC Cardiovascular Imaging, June 2010, Elsevier

    Prof. Carmine Zoccali

  173. Epidemiology of CKD in Europe: an uncertain scenario

    Article • Nephrology Dialysis Transplantation, May 2010, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  174. Mendelian randomization: use of genetics to enable causal inference in observational studies

    Article • Nephrology Dialysis Transplantation, February 2010, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  175. Statistical methods for the assessment of prognostic biomarkers(part II): calibration and re-classification

    Article • Nephrology Dialysis Transplantation, February 2010, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  176. Statistical methods for the assessment of prognostic biomarkers (Part I): Discrimination

    Article • Nephrology Dialysis Transplantation, February 2010, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  177. Blood pressure in chronic kidney disease stage 5D—report from a Kidney Disease: Improving Global Outcomes controversies conference

    Article • Kidney International, February 2010, Elsevier

    Prof. Carmine Zoccali

  178. Circulating soluble receptor of advanced glycation end product inversely correlates with atherosclerosis in patients with chronic kidney disease

    Article • Kidney International, February 2010, Elsevier

    Prof. Carmine Zoccali

  179. Sample size calculations: basic principles and common pitfalls

    Article • Nephrology Dialysis Transplantation, January 2010, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  180. Case-Control Studies – An Efficient Observational Study Design

    Article • Nephron Clinical Practice, January 2010, Karger Publishers

    Prof. Carmine Zoccali

  181. Confounding

    Article • Nephron Clinical Practice, January 2010, Karger Publishers

    Prof. Carmine Zoccali

  182. Cardiomyopathy in Chronic Kidney Disease and in End-stage Renal Disease

    Article • January 2010, Springer Science + Business Media

    Prof. Carmine Zoccali

  183. Endothelial Dysfunction, Nitric Oxide Bioavailability, and Asymmetric Dimethyl Arginine

    Article • January 2010, Springer Science + Business Media

    Prof. Carmine Zoccali

  184. Measures of Disease Frequency: Prevalence and Incidence

    Article • Nephron Clinical Practice, January 2010, Karger Publishers

    Prof. Carmine Zoccali

  185. Measures of Effect in Epidemiological Research

    Article • Nephron Clinical Practice, January 2010, Karger Publishers

    Prof. Carmine Zoccali

  186. Nebivolol Improves Renal Function in Patients Who Underwent Angioplasty due to Renal Artery Stenosis: A Pilot Study

    Article • Nephron Clinical Practice, January 2010, Karger Publishers

    Prof. Carmine Zoccali

  187. Observational Studies Are Complementary to Randomized Controlled Trials

    Article • Nephron Clinical Practice, January 2010, Karger Publishers

    Prof. Carmine Zoccali

  188. Prevalence and Prognosis of Mild Anemia in Non-Dialysis Chronic Kidney Disease: A Prospective Cohort Study in Outpatient Renal Clinics

    Article • American Journal of Nephrology, January 2010, Karger Publishers

    Prof. Carmine Zoccali

  189. Selection Bias and Information Bias in Clinical Research

    Article • Nephron Clinical Practice, January 2010, Karger Publishers

    Prof. Carmine Zoccali

  190. Soluble E-Selectin Is an Inverse and Independent Predictor of Left Ventricular Wall Thickness in End-Stage Renal Disease Patients

    Article • Nephron Clinical Practice, January 2010, Karger Publishers

    Prof. Carmine Zoccali

  191. Vitamin D receptor (VDR) gene polymorphism is associated with left ventricular (LV) mass and predicts left ventricular hypertrophy (LVH) progression in end-stage renal disease (ESRD) patients

    Article • Journal of Bone and Mineral Research, December 2009, Wiley

    Prof. Carmine Zoccali

  192. Methylarginines and mortality in patients with end stage renal disease: A prospective cohort study

    Article • Atherosclerosis, December 2009, Elsevier

    Prof. Carmine Zoccali

  193. Systematic reviews and meta-analyses: when they are useful and when to be careful

    Article • Kidney International, December 2009, Elsevier

    Prof. Carmine Zoccali

  194. The Databases: Renal Replacement Therapy Since 1989—The European Renal Association and European Dialysis and Transplant Association (ERA-EDTA)

    Article • Clinical Journal of the American Society of Nephrology, December 2009, American Society of Nephrology

    Prof. Carmine Zoccali

  195. Klotho Variants and Chronic Hemodialysis Mortality

    Article • Journal of Bone and Mineral Research, November 2009, Wiley

    Prof. Carmine Zoccali

  196. The Relationship between Hemoglobin Levels and Endothelial Functions in Diabetes Mellitus

    Article • Clinical Journal of the American Society of Nephrology, October 2009, American Society of Nephrology

    Prof. Carmine Zoccali

  197. Chronic kidney disease and end-stage renal disease--a review produced to contribute to the report 'the status of health in the European union: towards a healthier Europe'

    Article • Clinical Kidney Journal, October 2009, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  198. An update on renal replacement therapy in Europe: ERA-EDTA Registry data from 1997 to 2006

    Article • Nephrology Dialysis Transplantation, October 2009, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  199. Biomarkers of Left Atrial Volume

    Article • Hypertension, October 2009, Wolters Kluwer Health

    Prof. Carmine Zoccali

  200. Screening: why, when, and how

    Article • Kidney International, October 2009, Elsevier

    Prof. Carmine Zoccali

  201. The 2007 ERA-EDTA Registry Annual Report--a Precis

    Article • Clinical Kidney Journal, September 2009, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  202. The Randomized Controlled Trial

    Article • Nephron Clinical Practice, September 2009, Karger Publishers

    Prof. Carmine Zoccali

  203. Promoting scientific collaboration and education in cardiovascular-renal medicine: EURECAM: An ERA-EDTA-based working group

    Article • Clinical Kidney Journal, September 2009, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  204. The sweetness of glitazones: randomized trials needed

    Article • Nature Reviews Nephrology, September 2009, Springer Science + Business Media

    Prof. Carmine Zoccali

  205. Erratum

    Article • Current Opinion in Nephrology & Hypertension, September 2009, Wolters Kluwer Health

    Prof. Carmine Zoccali

  206. Diagnostic methods 2: receiver operating characteristic (ROC) curves

    Article • Kidney International, August 2009, Elsevier

    Prof. Carmine Zoccali

  207. Comorbidity data collection by renal registries--a remaining challenge

    Article • Nephrology Dialysis Transplantation, June 2009, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  208. Diagnostic methods I: sensitivity, specificity, and other measures of accuracy

    Article • Kidney International, June 2009, Elsevier

    Prof. Carmine Zoccali

  209. Hemoglobin is inversely related to flow-mediated dilatation in chronic kidney disease

    Article • Kidney International, June 2009, Elsevier

    Prof. Carmine Zoccali

  210. Sleep Disordered Breathing in Renal Transplant Patients

    Article • American Journal of Transplantation, June 2009, Wiley

    Prof. Carmine Zoccali

  211. Reply

    Article • Nephrology Dialysis Transplantation, May 2009, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  212. Abdominal Obesity and All-Cause and Cardiovascular Mortality in End-Stage Renal Disease

    Article • Journal of the American College of Cardiology, April 2009, Elsevier

    Prof. Carmine Zoccali

  213. The effect of joint exposures: examining the presence of interaction

    Article • Kidney International, April 2009, Elsevier

    Prof. Carmine Zoccali

  214. The future of European Nephrology 'Guidelines'--a declaration of intent by European Renal Best Practice (ERBP)

    Article • Clinical Kidney Journal, March 2009, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  215. Blood pressure control: hydrogen sulfide, a new gasotransmitter, takes stage

    Article • Nephrology Dialysis Transplantation, February 2009, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  216. Out-of-office blood pressure monitoring in chronic kidney disease

    Article • Blood Pressure Monitoring, February 2009, Wolters Kluwer Health

    Prof. Carmine Zoccali

  217. Clinical Implications of Elevated Asymmetric Dimethylarginine in Chronic Kidney Disease and End-Stage Renal Disease

    Article • Journal of Renal Nutrition, January 2009, Elsevier

    Prof. Carmine Zoccali

  218. Cohort Studies: Prospective versus Retrospective

    Article • Nephron Clinical Practice, January 2009, Karger Publishers

    Prof. Carmine Zoccali

  219. Study Designs in Clinical Research

    Article • Nephron Clinical Practice, January 2009, Karger Publishers

    Prof. Carmine Zoccali

  220. Thyroid, Renal Function, and Cardiac Outcome

    Article • January 2009, Springer Science + Business Media

    Prof. Carmine Zoccali

  221. Vitamin D levels and patient outcome in chronic kidney disease

    Article • Kidney International, January 2009, Elsevier

    Prof. Carmine Zoccali

  222. FGF-23 in dialysis patients: ready for prime time?

    Article • Nephrology Dialysis Transplantation, December 2008, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  223. Gammaglutamyltransferase in ESRD as a predictor of all-cause and cardiovascular mortality: another facet of oxidative stress burden

    Article • Kidney International, December 2008, Elsevier

    Prof. Carmine Zoccali

  224. Testing for causality and prognosis: etiological and prognostic models

    Article • Kidney International, December 2008, Elsevier

    Prof. Carmine Zoccali

  225. The obesity epidemics in ESRD: from wasting to waist?

    Article • Nephrology Dialysis Transplantation, November 2008, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  226. Agreement between methods

    Article • Kidney International, November 2008, Elsevier

    Prof. Carmine Zoccali

  227. Asymmetric dimethylarginine: a novel marker of risk and a potential target for therapy in chronic kidney disease

    Article • Current Opinion in Nephrology & Hypertension, November 2008, Wolters Kluwer Health

    Prof. Carmine Zoccali

  228. Type-2 diabetes and endothelial dysfunction: exploring the road to disease in the reverse direction

    Article • Journal of Hypertension, November 2008, Wolters Kluwer Health

    Prof. Carmine Zoccali

  229. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement

    Article • Nephrology Dialysis Transplantation, October 2008, Oxford University Press (OUP)

    Professor Geert Leroux-Roels, Prof. Carmine Zoccali

  230. Survival analysis: time-dependent effects and time-varying risk factors

    Article • Kidney International, October 2008, Elsevier

    Prof. Carmine Zoccali

  231. The analysis of survival data in nephrology: basic concepts and methods of Cox regression

    Article • Kidney International, September 2008, Elsevier

    Prof. Carmine Zoccali

  232. The analysis of survival data: the Kaplan–Meier method

    Article • Kidney International, September 2008, Elsevier

    Prof. Carmine Zoccali

  233. Vascular endothelial growth factor, left ventricular dysfunction and mortality in hemodialysis patients

    Article • Journal of Hypertension, September 2008, Wolters Kluwer Health

    Prof. Carmine Zoccali

  234. Biosimilars and biopharmaceuticals: what the nephrologists need to know--a position paper by the ERA-EDTA Council

    Article • Nephrology Dialysis Transplantation, July 2008, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  235. Obesity, diabetes, adiponectin and the kidney: a podocyte affair

    Article • Nephrology Dialysis Transplantation, July 2008, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  236. Kidney Function and Risk Factors for Left Ventricular Hypertrophy in Untreated Uncomplicated Essential Hypertension

    Article • American Journal of Kidney Diseases, July 2008, Elsevier

    Prof. Carmine Zoccali

  237. European best practice quo vadis? From European best practice guidelines (EBPG) to European renal best practice (ERBP)

    Article • Nephrology Dialysis Transplantation, May 2008, Oxford University Press (OUP)

    Professor maurizio salvadori, Prof. Carmine Zoccali

  238. Linear and logistic regression analysis

    Article • Kidney International, April 2008, Elsevier

    Prof. Carmine Zoccali

  239. Endogenous ouabain and cardiomyopathy in dialysis patients

    Article • Journal of Internal Medicine, March 2008, Wiley

    Prof. Carmine Zoccali

  240. Urotensin II: a cardiovascular and renal update

    Article • Current Opinion in Nephrology & Hypertension, March 2008, Wolters Kluwer Health

    Prof. Carmine Zoccali

  241. C.E.R.A. Corrects Anemia in Patients with Chronic Kidney Disease not on Dialysis: Results of a Randomized Clinical Trial

    Article • Clinical Journal of the American Society of Nephrology, February 2008, American Society of Nephrology

    Prof. Carmine Zoccali

  242. Screening for Chronic Kidney Disease: Where Does Europe Go?

    Article • Clinical Journal of the American Society of Nephrology, February 2008, American Society of Nephrology

    Prof. Carmine Zoccali

  243. Cardiovascular risk in patients with chronic kidney disease: Not high enough to enter the major league?

    Article • Current Hypertension Reports, February 2008, Springer Science + Business Media

    Prof. Carmine Zoccali

  244. Confounding: What it is and how to deal with it

    Article • Kidney International, February 2008, Elsevier

    Prof. Carmine Zoccali

  245. Urotensin II and Cardiomyopathy in End-Stage Renal Disease

    Article • Hypertension, February 2008, Wolters Kluwer Health

    Prof. Carmine Zoccali

  246. Rate of Atherosclerotic Plaque Formation Predicts Cardiovascular Events in ESRD

    Article • Journal of the American Society of Nephrology, January 2008, American Society of Nephrology

    Prof. Carmine Zoccali

  247. Dietary Modulation of the Inflammatory Response

    Article • January 2008, Elsevier

    Professor Raffaele De Caterina, Prof. Carmine Zoccali

  248. Bias in clinical research

    Article • Kidney International, January 2008, Elsevier

    Prof. Carmine Zoccali

  249. The Burden of Cardiovascular Disease in Patients with Chronic Kidney Disease and in End-Stage Renal Disease

    Article • January 2008, Karger Publishers

    Prof. Carmine Zoccali

  250. Urotensin II is an inverse predictor of death and fatal cardiovascular events in chronic kidney disease

    Article • Kidney International, January 2008, Elsevier

    Prof. Carmine Zoccali

  251. Neuropeptide Y and Markers of Osteoblast Activity in Dialysis Patients: A Cross-Sectional Study

    Article • American Journal of Kidney Diseases, December 2007, Elsevier

    Prof. Carmine Zoccali

  252. Clinical policies on the management of chronic kidney disease patients in Italy

    Article • Nephrology Dialysis Transplantation, October 2007, Oxford University Press (OUP)

    Prof. Maurizio Gallieni, Prof. Carmine Zoccali

  253. Endothelial dysfunction in CKD: a new player in town?

    Article • Nephrology Dialysis Transplantation, October 2007, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  254. Endothelial Dysfunction and C-Reactive Protein Are Risk Factors for Diabetes in Essential Hypertension

    Article • Diabetes, October 2007, American Diabetes Association

    Prof. Carmine Zoccali

  255. Circulating E-selectin as a risk marker in patients with end-stage renal disease

    Article • Journal of Internal Medicine, October 2007, Wiley

    Prof. Carmine Zoccali

  256. Dry Mouth in Dialysis Patients

    Article • Seminars in Dialysis, October 2007, Wiley

    Prof. Carmine Zoccali

  257. Measures of effect: Relative risks, odds ratios, risk difference, and ‘number needed to treat’

    Article • Kidney International, October 2007, Elsevier

    Prof. Carmine Zoccali

  258. Nocturnal Hypoxemia: A Cardiovascular Risk Factor in Dialysis Patients

    Article • Seminars in Dialysis, October 2007, Wiley

    Prof. Carmine Zoccali

  259. Guest Editor: Rajiv Agarwal: Cardiovascular Risk Profile Assessment and Medication Control Should Come First

    Article • Seminars in Dialysis, September 2007, Wiley

    Prof. Carmine Zoccali

  260. The randomized clinical trial: An unbeatable standard in clinical research?

    Article • Kidney International, September 2007, Elsevier

    Prof. Carmine Zoccali

  261. The valuable contribution of observational studies to nephrology

    Article • Kidney International, September 2007, Elsevier

    Prof. Carmine Zoccali

  262. Searching for biomarker patterns characterizing carotid atherosclerotic burden in patients with reduced renal function

    Article • Nephrology Dialysis Transplantation, August 2007, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  263. CARDIOVASCULAR AND SURVIVAL PARADOXES IN DIALYSIS PATIENTS: It Is Important to Lower Homocysteine in Dialysis Patients

    Article • Seminars in Dialysis, August 2007, Wiley

    Prof. Carmine Zoccali

  264. General and clinical epidemiology at square two: A new educational series for the renal physician

    Article • Kidney International, August 2007, Elsevier

    Prof. Carmine Zoccali

  265. Measuring disease occurrence

    Article • Kidney International, August 2007, Elsevier

    Prof. Carmine Zoccali

  266. An Additive Effect of Endothelial Nitric Oxide Synthase Gene Polymorphisms Contributes to the Severity of Atherosclerosis in Patients on Dialysis

    Article • American Journal of Hypertension, July 2007, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  267. Adiponectin and renal disease progression: Another epidemiologic conundrum?

    Article • Kidney International, June 2007, Elsevier

    Prof. Carmine Zoccali

  268. The Kidney Disease: Improving Global Outcomes website: Comparison of guidelines as a tool for harmonization

    Article • Kidney International, May 2007, Elsevier

    Prof. Carmine Zoccali

  269. A New Perspective for the Treatment of Renal Diseases?

    Article • Journal of the American Society of Nephrology, April 2007, American Society of Nephrology

    Prof. Carmine Zoccali

  270. How important is echocardiography for risk stratification in follow-up of patients with chronic kidney disease?

    Article • Nature Clinical Practice Nephrology, April 2007, Springer Science + Business Media

    Prof. Carmine Zoccali

  271. Left Atrial Volume Monitoring and Cardiovascular Risk in Patients with End-Stage Renal Disease: A Prospective Cohort Study

    Article • Journal of the American Society of Nephrology, March 2007, American Society of Nephrology

    Prof. Carmine Zoccali

  272. Prognostic value of the New York Heart Association classification in end-stage renal disease

    Article • Nephrology Dialysis Transplantation, March 2007, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  273. Quality of care in end-stage renal disease: the importance of comparing 'apples with apples'

    Article • Nephrology Dialysis Transplantation, January 2007, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  274. Asymmetric dimethyl-arginine (ADMA) response to inflammation in acute infections

    Article • Nephrology Dialysis Transplantation, January 2007, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  275. Clinical Databases and the QUEST Initiative

    Article • Blood Purification, January 2007, Karger Publishers

    Prof. Carmine Zoccali

  276. Asymmetric dimethylarginine in end-stage renal disease patients: A biomarker modifiable by calcium blockade and angiotensin II antagonism?

    Article • Kidney International, December 2006, Elsevier

    Prof. Carmine Zoccali

  277. Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol

    Article • Biochimie, December 2006, Elsevier

    Prof. Carmine Zoccali

  278. Dissecting Inflammation in ESRD: Do Cytokines and C-Reactive Protein Have a Complementary Prognostic Value for Mortality in Dialysis Patients?

    Article • Journal of the American Society of Nephrology, November 2006, American Society of Nephrology

    Prof. Carmine Zoccali

  279. Urotensin in ESRD: Not so surprising

    Article • Kidney International, November 2006, Elsevier

    Prof. Carmine Zoccali

  280. Low triiodothyronine and cardiomyopathy in patients with end-stage renal disease

    Article • Journal of Hypertension, October 2006, Wolters Kluwer Health

    Prof. Carmine Zoccali

  281. Subclinical hypothyroidism is linked to micro-inflammation and predicts death in continuous ambulatory peritoneal dialysis

    Article • Nephrology Dialysis Transplantation, September 2006, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  282. Endothelial dysfunction in subcutaneous small resistance arteries and cardiovascular events

    Article • Journal of Hypertension, September 2006, Wolters Kluwer Health

    Prof. Carmine Zoccali

  283. Letter by Kielstein et al Regarding Article, “Renal Function as a Predictor of Outcome in a Broad Spectrum of Patients With Heart Failure”

    Article • Circulation, August 2006, Wolters Kluwer Health

    Prof. Carmine Zoccali

  284. A green light for troponin T in the cardiovascular risk stratification of continuous ambulatory peritoneal dialysis patients?

    Article • Kidney International, August 2006, Elsevier

    Prof. Carmine Zoccali

  285. ADMA, proteinuria, and insulin resistance in non-diabetic stage I chronic kidney disease

    Article • Kidney International, August 2006, Elsevier

    Prof. Carmine Zoccali

  286. Low triiodothyronine and survival in end-stage renal disease

    Article • Kidney International, August 2006, Elsevier

    Prof. Carmine Zoccali

  287. Traditional and emerging cardiovascular and renal risk factors: An epidemiologic perspective

    Article • Kidney International, July 2006, Elsevier

    Prof. Carmine Zoccali

  288. Left atrial volume in end-stage renal disease: a prospective cohort study

    Article • Journal of Hypertension, June 2006, Wolters Kluwer Health

    Prof. Carmine Zoccali

  289. Asymmetric dimethylarginine: a new player in the pathogenesis of renal disease?

    Article • Current Opinion in Nephrology & Hypertension, May 2006, Wolters Kluwer Health

    Prof. Carmine Zoccali

  290. Urotensin II and Biomarkers of Endothelial Activation and Atherosclerosis in End-Stage Renal Disease

    Article • American Journal of Hypertension, May 2006, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  291. Pre- and Postdialysis Blood Pressures Are Imprecise Estimates of Interdialytic Ambulatory Blood Pressure

    Article • Clinical Journal of the American Society of Nephrology, April 2006, American Society of Nephrology

    Prof. Carmine Zoccali

  292. Uric Acid and Endothelial Dysfunction in Essential Hypertension

    Article • Journal of the American Society of Nephrology, April 2006, American Society of Nephrology

    Prof. Carmine Zoccali

  293. Left Ventricular Systolic Function Monitoring in Asymptomatic Dialysis Patients: A Prospective Cohort Study

    Article • Journal of the American Society of Nephrology, April 2006, American Society of Nephrology

    Prof. Carmine Zoccali

  294. Asymmetric dimethylarginine (ADMA): a cardiovascular and renal risk factor on the move

    Article • Journal of Hypertension, April 2006, Wolters Kluwer Health

    Prof. Carmine Zoccali

  295. Renal impairment: a risk factor for ischemic heart disease

    Article • Current Opinion in Pharmacology, April 2006, Elsevier

    Prof. Carmine Zoccali

  296. Urotensin II is an inverse predictor of incident cardiovascular events in end-stage renal disease

    Article • Kidney International, April 2006, Elsevier

    Prof. Carmine Zoccali

  297. Endothelial Dysfunction and the Kidney: Emerging Risk Factors for Renal Insufficiency and Cardiovascular Outcomes in Essential Hypertension

    Article • Journal of the American Society of Nephrology, March 2006, American Society of Nephrology

    Prof. Carmine Zoccali

  298. Inflammation as a Mediator of the Link between Mild to Moderate Renal Insufficiency and Endothelial Dysfunction in Essential Hypertension

    Article • Journal of the American Society of Nephrology, March 2006, American Society of Nephrology

    Prof. Carmine Zoccali

  299. The E-selectin gene polymorphism and carotid atherosclerosis in end-stage renal disease

    Article • Nephrology Dialysis Transplantation, March 2006, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  300. About the manuscript of Nishitani Y et al. (Kidney Int 2005; 68: 1078–1085)

    Article • Kidney International, March 2006, Elsevier

    Prof. Carmine Zoccali

  301. Kidney Diseases in the Developing World and Ethnic Minorities

    Article • American Journal of Kidney Diseases, March 2006, Elsevier

    Prof. Carmine Zoccali

  302. Global approach to cardiovascular risk in chronic kidney disease: Reality and opportunities for intervention

    Article • Kidney International, February 2006, Elsevier

    Prof. Carmine Zoccali

  303. Mendelian Randomization: A New Approach to Studying Epidemiology in ESRD

    Article • American Journal of Kidney Diseases, February 2006, Elsevier

    Prof. Carmine Zoccali

  304. The Determinants of Endothelial Dysfunction in CKD: Oxidative Stress and Asymmetric Dimethylarginine

    Article • American Journal of Kidney Diseases, January 2006, Elsevier

    Professor Cengizhan ACIKEL, Prof. Carmine Zoccali

  305. Homocysteine and risk in end-stage renal disease: a matter of context

    Article • Kidney International, January 2006, Elsevier

    Prof. Carmine Zoccali

  306. Is silent cerebral infarction associated with vascular events in patients undergoing hemodialysis?

    Article • Nature Clinical Practice Nephrology, January 2006, Springer Science + Business Media

    Prof. Carmine Zoccali

  307. Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients

    Article • Nephrology Dialysis Transplantation, December 2005, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  308. Is oxidative stress implicated in high bone turnover in end-stage renal disease (ESRD)?

    Article • Nephrology Dialysis Transplantation, December 2005, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  309. Atherosclerosis and the Glu298Asp Polymorphism of the eNOS Gene in White Patients With End-Stage Renal Disease

    Article • American Journal of Hypertension, December 2005, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  310. Are Homocysteine and MTHFR Genotype Polymorphism Associated with Arteriovenous Fistula Patency?

    Article • American Journal of Kidney Diseases, November 2005, Elsevier

    Prof. Carmine Zoccali

  311. In Reply

    Article • American Journal of Kidney Diseases, November 2005, Elsevier

    Prof. Carmine Zoccali

  312. Predictors of Cardiovascular Death in ESRD

    Article • Seminars in Nephrology, November 2005, Elsevier

    Prof. Carmine Zoccali

  313. Asymmetric dimethylarginine (ADMA) as a cardiovascular risk factor in end-stage renal disease (ESRD)

    Article • European Journal of Clinical Pharmacology, September 2005, Springer Science + Business Media

    Prof. Carmine Zoccali

  314. Prognostic value of 24-hour ambulatory blood pressure monitoring and of night/day ratio in nondiabetic, cardiovascular events-free hemodialysis patients

    Article • Kidney International, September 2005, Elsevier

    Prof. Carmine Zoccali

  315. QUality European STudies (QUEST)–a step forward in the quality of RRT care

    Article • Nephrology Dialysis Transplantation, September 2005, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  316. Asymmetric Dimethylarginine, L-Arginine, and Endothelial Dysfunction in Essential Hypertension

    Article • Journal of the American College of Cardiology, August 2005, Elsevier

    Prof. Carmine Zoccali

  317. Asymmetric Dimethylarginine: A Cardiovascular Risk Factor and a Uremic Toxin Coming of Age?

    Article • American Journal of Kidney Diseases, August 2005, Elsevier

    Prof. Carmine Zoccali

  318. Low Triiodothyronine: A New Facet of Inflammation in End-Stage Renal Disease

    Article • Journal of the American Society of Nephrology, July 2005, American Society of Nephrology

    Prof. Carmine Zoccali

  319. Asymmetrical Dimethylarginine Predicts Progression to Dialysis and Death in Patients with Chronic Kidney Disease: A Competing Risks Modeling Approach

    Article • Journal of the American Society of Nephrology, June 2005, American Society of Nephrology

    Prof. Carmine Zoccali

  320. Prognostic value of combined use of biomarkers of inflammation, endothelial dysfunction, and myocardiopathy in patients with ESRD

    Article • Kidney International, June 2005, Elsevier

    Prof. Carmine Zoccali

  321. Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patients

    Article • American Journal of Kidney Diseases, April 2005, Elsevier

    Prof. Carmine Zoccali

  322. Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial

    Article • The Lancet, March 2005, Elsevier

    Prof. Carmine Zoccali

  323. Inflammation Markers, Adhesion Molecules, and All-Cause and Cardiovascular Mortality in Patients with ESRD: Searching for the Best Risk Marker by Multivariate Modeling

    Article • Journal of the American Society of Nephrology, March 2005, American Society of Nephrology

    Prof. Carmine Zoccali

  324. Parasympathetic neuropathy and LVH

    Article • Nephrology Dialysis Transplantation, February 2005, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  325. Adipose tissue cytokines, insulin sensitivity, inflammation, and cardiovascular outcomes in end-stage renal disease patients

    Article • Journal of Renal Nutrition, January 2005, Elsevier

    Prof. Carmine Zoccali

  326. Neuropeptide Y as a far-reaching neuromediator: from energy balance and cardiovascular regulation to central integration of weight and bone mass control mechanisms. Implications for human diseases

    Article • Current Opinion in Nephrology & Hypertension, January 2005, Wolters Kluwer Health

    Prof. Carmine Zoccali

  327. Endothelial Dysfunction and Mild Renal Insufficiency in Essential Hypertension

    Article • Circulation, August 2004, Wolters Kluwer Health

    Prof. Carmine Zoccali

  328. Inflammatory proteins as predictors of cardiovascular disease in patients with end-stage renal disease

    Article • Nephrology Dialysis Transplantation, August 2004, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  329. HYPERTENSION IN HEMODIALYSIS PATIENTS: Cardiac Consequences of Hypertension in Hemodialysis Patients

    Article • Seminars in Dialysis, July 2004, Wiley

    Prof. Carmine Zoccali

  330. Achievement of target blood pressure levels in chronic kidney disease: a salty question?

    Article • American Journal of Kidney Diseases, May 2004, Elsevier

    Prof. Carmine Zoccali

  331. Left ventricular mass monitoring in the follow-up of dialysis patients: Prognostic value of left ventricular hypertrophy progression

    Article • Kidney International, April 2004, Elsevier

    Prof. Carmine Zoccali

  332. Prognostic Value of Echocardiographic Indicators of Left Ventricular Systolic Function in Asymptomatic Dialysis Patients

    Article • Journal of the American Society of Nephrology, April 2004, American Society of Nephrology

    Prof. Carmine Zoccali

  333. Heart valve calcifications, survival, and cardiovascular risk in hemodialysis patients

    Article • American Journal of Kidney Diseases, March 2004, Elsevier

    Prof. Carmine Zoccali

  334. In reply

    Article • American Journal of Kidney Diseases, March 2004, Elsevier

    Prof. Carmine Zoccali

  335. Analysis of the Relationship between Norepinephrine and Asymmetric Dimethyl Arginine Levels among Patients with End-Stage Renal Disease

    Article • Journal of the American Society of Nephrology, February 2004, American Society of Nephrology

    Prof. Carmine Zoccali

  336. ADMA: a novel risk factor that explains excess cardiovascular event rate in patients with end-stage renal disease

    Article • Atherosclerosis Supplements, December 2003, Elsevier

    Prof. Carmine Zoccali

  337. Genetic polymorphism of the renin???angiotensin???aldosterone system and arterial hypertension in the Italian population

    Article • Journal of Hypertension, October 2003, Wolters Kluwer Health

    Prof. Carmine Zoccali

  338. Salivary and lacrimal secretion is reduced in patients with ESRD

    Article • American Journal of Kidney Diseases, October 2003, Elsevier

    Prof. Carmine Zoccali

  339. Prospective Study of Neuropeptide Y as an Adverse Cardiovascular Risk Factor in End-Stage Renal Disease

    Article • Journal of the American Society of Nephrology, September 2003, American Society of Nephrology

    Prof. Carmine Zoccali

  340. The importance of diabetic nephropathy in current nephrological practice

    Article • Nephrology Dialysis Transplantation, September 2003, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  341. Chlamydia pneumoniae, overall and cardiovascular mortality in end-stage renal disease (ESRD)

    Article • Kidney International, August 2003, Elsevier

    Prof. Carmine Zoccali

  342. Fibrinogen, mortality and incident cardiovascular complications in end-stage renal failure

    Article • Journal of Internal Medicine, August 2003, Wiley

    Prof. Carmine Zoccali

  343. Neuropeptide Y, left ventricular mass and function in patients with end stage renal disease

    Article • Journal of Hypertension, July 2003, Wolters Kluwer Health

    Prof. Carmine Zoccali

  344. Fibrinogen, inflammation and concentric left ventricular hypertrophy in chronic renal failure

    Article • European Journal of Clinical Investigation, June 2003, Wiley

    Prof. Carmine Zoccali

  345. Salt sensitivity phenotype

    Article • Journal of Hypertension, May 2003, Wolters Kluwer Health

    Prof. Carmine Zoccali

  346. Adma: a critical cardio-renal link in heart failure?

    Article • European Journal of Clinical Investigation, April 2003, Wiley

    Prof. Carmine Zoccali

  347. Arterial pressure components and cardiovascular risk in end-stage renal disease

    Article • Nephrology Dialysis Transplantation, February 2003, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  348. Hepatocyte Growth Factor and Left Ventricular Geometry in End-Stage Renal Disease

    Article • Hypertension, January 2003, Wolters Kluwer Health

    Prof. Carmine Zoccali

  349. Inflammation and Atherosclerosis in End-Stage Renal Disease

    Article • Blood Purification, January 2003, Karger Publishers

    Prof. Carmine Zoccali

  350. In reply to Król

    Article • American Journal of Kidney Diseases, December 2002, Elsevier

    Prof. Carmine Zoccali

  351. Increased cardiac troponin T is linked to the type of renal replacement therapy

    Article • American Journal of Kidney Diseases, December 2002, Elsevier

    Prof. Carmine Zoccali

  352. Diagnostic value of troponin T for alterations in left ventricular mass and function in dialysis patients

    Article • Kidney International, November 2002, Elsevier

    Prof. Carmine Zoccali

  353. Inflammation and outcome in end-stage renal failure: Does female gender constitute a survival advantage?

    Article • Kidney International, November 2002, Elsevier

    Prof. Carmine Zoccali

  354. Low parathyroid hormone and pentosidine in hemodialysis patients

    Article • American Journal of Kidney Diseases, October 2002, Elsevier

    Prof. Carmine Zoccali

  355. Left ventricular hypertrophy, cardiac remodeling and asymmetric dimethylarginine (ADMA) in hemodialysis patients

    Article • Kidney International, July 2002, Elsevier

    Prof. Carmine Zoccali

  356. Norepinephrine and Concentric Hypertrophy in Patients With End-Stage Renal Disease

    Article • Hypertension, July 2002, Wolters Kluwer Health

    Prof. Carmine Zoccali

  357. Troponin is related to left ventricular mass and predicts all-cause and cardiovascular mortality in hemodialysis patients

    Article • American Journal of Kidney Diseases, July 2002, Elsevier

    Prof. Carmine Zoccali

  358. The oscillometric wrist devices: an estimate of the ‘supine’ error

    Article • Journal of Human Hypertension, June 2002, Springer Science + Business Media

    Prof. Carmine Zoccali

  359. Plasma Norepinephrine Predicts Survival and Incident Cardiovascular Events in Patients With End-Stage Renal Disease

    Article • Circulation, March 2002, Wolters Kluwer Health

    Prof. Carmine Zoccali

  360. Prediction of hypertension in hemodialysis patients

    Article • Kidney International, March 2002, Elsevier

    Prof. Carmine Zoccali

  361. Hyperhomocysteinemia predicts cardiovascular outcomes in hemodialysis patients

    Article • Kidney International, February 2002, Elsevier

    Prof. Carmine Zoccali

  362. Endothelial Damage, Asymmetric Dimethylarginine and Cardiovascular Risk in End-Stage Renal Disease

    Article • Blood Purification, January 2002, Karger Publishers

    Prof. Carmine Zoccali

  363. Nocturnal Hypoxemia: A Neglected Cardiovascular Risk Factor in End-Stage Renal Disease?

    Article • Blood Purification, January 2002, Karger Publishers

    Prof. Carmine Zoccali

  364. Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study

    Article • The Lancet, December 2001, Elsevier

    Prof. Carmine Zoccali

  365. Diagnostic potential of cardiac natriuretic peptides in dialysis patients

    Article • Kidney International, April 2001, Elsevier

    Prof. Carmine Zoccali

  366. Urinary adrenomedullin is related to ET-1 and salt intake in patients with mild essential hypertension

    Article • American Journal of Hypertension, March 2001, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  367. Left ventricular hypertrophy and nocturnal hypoxemia in hemodialysis patients

    Article • Journal of Hypertension, February 2001, Wolters Kluwer Health

    Prof. Carmine Zoccali

  368. Gender-dependent differences in plasma leptin in essential hypertension

    Article • American Journal of Hypertension, August 2000, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  369. The deletion polymorphism of the angiotensin-converting enzyme is associated with nephroangiosclerosis

    Article • American Journal of Hypertension, April 2000, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  370. ACE genotype and ACE inhibitors induced renoprotection in chronic proteinuric nephropathies1

    Article • Kidney International, January 2000, Elsevier

    Prof. Carmine Zoccali

  371. Prediction of left ventricular geometry by clinic, pre-dialysis and 24-h ambulatory BP monitoring in hemodialysis patients

    Article • Journal of Hypertension, December 1999, Wolters Kluwer Health

    Prof. Carmine Zoccali

  372. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria

    Article • The Lancet, July 1999, Elsevier

    Professor maurizio salvadori, Professor Maurizio Salvadori, Prof. Carmine Zoccali

  373. Ambulatory monitoring and clinic BP measurements for predicting left ventricular mass in patients with chronic renal diseases

    Article • Nephrology Dialysis Transplantation, January 1999, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  374. Plasma adrenomedullin during acute changes in intravascular volume in hemodialysis patients

    Article • Kidney International, November 1998, Elsevier

    Prof. Carmine Zoccali

  375. Nocturnal hypoxemia, night-day arterial pressure changes and left ventricular geometry in dialysis patients

    Article • Kidney International, April 1998, Elsevier

    Prof. Carmine Zoccali

  376. Another ‘Epidemic’ of Spontaneous Rupture of Peritoneal Catheters

    Article • January 1998, Karger Publishers

    Prof. Carmine Zoccali

  377. Salt, resting arterial pressure and 24 h monitoring

    Article • Journal of Hypertension, April 1997, Wolters Kluwer Health

    Prof. Carmine Zoccali

  378. The heart rate response pattern to dialysis hypotension in haemodialysis patients

    Article • Nephrology Dialysis Transplantation, March 1997, Oxford University Press (OUP)

    Prof. Carmine Zoccali

  379. Reproducibility of the response to short-term low salt intake in essential hypertension

    Article • Journal of Hypertension, December 1996, Wolters Kluwer Health

    Prof. Carmine Zoccali

  380. Influence of Cardiovascular Damage and Residual Renal Function on Plasma Endothelin in Chronic Renal Failure

    Article • January 1993, Karger Publishers

    Prof. Carmine Zoccali

  381. Effects of Potassium on Sodium Balance, Renin, Noradrenaline and Arterial Pressure

    Article • Journal of Hypertension, February 1985, Wolters Kluwer Health

    Prof. Carmine Zoccali

  382. Effect of the 5-hydroxytryptamine type 2 receptor antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympatho-adrenal function in patients with essential hypertension.

    Article • British Journal of Clinical Pharmacology, March 1984, Wiley

    Prof. Carmine Zoccali

  383. Enalapril (MK421) and its lysine analogue (MK521): a comparison of acute and chronic effects on blood pressure, renin-angiotensin system and sodium excretion in normal man.

    Article • British Journal of Clinical Pharmacology, March 1984, Wiley

    Prof. Carmine Zoccali

  384. Is Metenkephalin Responsible for the Baroreflex Dysfunction of Chronic Uraemics?

    Article • Clinical and Experimental Hypertension Part A Theory and Practice, January 1984, Taylor & Francis

    Prof. Carmine Zoccali

  385. The effect of a 5-HT antagonist, ketanserin, on blood pressure, the renin-angiotensin system and sympathoadrenal function in normal man.

    Article • British Journal of Clinical Pharmacology, September 1983, Wiley

    Prof. Carmine Zoccali

  386. A comparison of the effects of angiotensin II infusion and variations in salt intake on plasma aldosterone levels in normal subjects, patients with essential hypertension and patients with hyperaldosteronism

    Article • Journal of Steroid Biochemistry, July 1983, Elsevier

    Prof. Carmine Zoccali

  387. The Renal Tubular Defect of Bartter’s Syndrome

    Article • January 1982, Karger Publishers

    Prof. Carmine Zoccali